title: Toxicity of irradiated advanced heavy water reactor fuels.
abstract: The good neutron economy and online refueling capability of the CANDU® heavy water moderated reactor (HWR) enable it to use many different fuels such as low enriched uranium (LEU), plutonium, or thorium, in addition to its traditional natural uranium (NU) fuel. The toxicity and radiological protection methods for these proposed fuels, unlike those for NU, are not well established. This study uses software to compare the fuel composition and toxicity of irradiated NU fuel against those of two irradiated advanced HWR fuel bundles as a function of post-irradiation time. The first bundle investigated is a CANFLEX® low void reactor fuel (LVRF), of which only the dysprosium-poisoned central element, and not the outer 42 LEU elements, is specifically analyzed. The second bundle investigated is a heterogeneous high-burnup (LEU,Th)O(2) fuelled bundle, whose two components (LEU in the outer 35 elements and thorium in the central eight elements) are analyzed separately. The LVRF central element was estimated to have a much lower toxicity than that of NU at all times after shutdown. Both the high burnup LEU and the thorium fuel had similar toxicity to NU at shutdown, but due to the creation of such inhalation hazards as (238)Pu, (240)Pu, (242)Am, (242)Cm, and (244)Cm (in high burnup LEU), and (232)U and (228)Th (in irradiated thorium), the toxicity of these fuels was almost double that of irradiated NU after 2,700 d of cooling. New urine bioassay methods for higher actinoids and the analysis of thorium in fecal samples are recommended to assess the internal dose from these two fuels.
authors.affiliation: Atomic Energy of Canada Ltd. Chalk River Laboratories, Chalk River Ontario, K0J 1J0, Canada. priestn@aecl.ca
authors.forename: N D
authors.initials: ND
authors.lastname: Priest
authors.forename: R B
authors.initials: RB
authors.lastname: Richardson
authors.forename: G W R
authors.initials: GW
authors.lastname: Edwards
mesh_terms: D001681:Biological Assay; D001682:Biological Availability; D017666:Deuterium Oxide / Q000737:chemistry*; D006801:Humans; D007700:Kinetics; D009688:Nuclear Reactors; D016273:Occupational Exposure / Q000009:adverse effects / Q000032:analysis; D011835:Radiation Protection; D011853:Radiobiology; D011868:Radioisotopes / Q000737:chemistry* / Q000493:pharmacokinetics / Q000633:toxicity* / Q000652:urine; D011874:Radiometry; D012984:Software; D014501:Uranium / Q000737:chemistry / Q000493:pharmacokinetics / Q000633:toxicity / Q000652:urine
chemical_list: D011868:Radioisotopes; D014501:Uranium; D017666:Deuterium Oxide